You are here :
Home
Healthcare
infertility Treatment
PAYMENT LINK _ Drug Discovery Services Market by Process (Target Selection, Hit-to-Lead Identification, Lead Optimization), Type (Medicinal Chemistry, Biology Services, DMPK), Drug Type (Small Molecules, Biologics), Therapeutic Areas (Oncology, Neurology) - Forecast to 2022
Global Transdermal Drug Delivery Systems Market
Global Active Market Research Report
- Report Code: AC 1000
- Publish Date: Upcoming
Active and Microfluidics, Smart Pill Technology (SPT) and Passive adds up to total Transdermal Drug Delivery Systems market.
Active can be segmented by Technologies and Types. Technologies of this market are Microfluidics and Smart Pill Technology (SPT). Types of this market are Microporation and Iontophoresis .
Active can be segmented by Technologies and Types. Technologies of this market are Microfluidics and Smart Pill Technology (SPT). Types of this market are Microporation and Iontophoresis .
Key Questions Answered
- What are market estimates and forecasts; which of Active markets are doing well and which are not?
- This report provides market sizing and forecast for the Active market. It also provides market sizing and forecast along with the drivers/inhibitors/opportunity analysis for each of the micro markets.
- Global Active companies
- Manufacturing Companies
- Traders, distributors, and suppliers
- Governmental and research organizations
- Associations and industry bodies
- Technology providers
What makes our report unique?
Audience for this report
1 Introduction
1.1 Analyst Insights
1.2 Market Definitions
1.3 Market Segmentation & Aspects Covered
1.4 Research Methodology
2 Executive Summary
3 Market Overview
4 By Technologies
4.1 Microfluidics
4.2 Smart Pill Technology (SPT)
5 By Types
5.1 Microporation
5.2 Iontophoresis
Please fill in the form below to receive a free copy of the Summary of this Report
Custom Market Research Services
We will customize the research for you, in case the report listed above does not
meet with your exact requirements. Our custom research will comprehensively cover
the business information you require to help you arrive at strategic and profitable
business decisions.
Please visit http://www.micromarketmonitor.com/custom-research-services.html to specify your custom Research Requirement
Please visit http://www.micromarketmonitor.com/custom-research-services.html to specify your custom Research Requirement
| PRODUCT TITLE | PUBLISHED | |
|---|---|---|
|
|
Microporation Microporation and Iontophoresis adds up to total Active market. ... |
Upcoming |
|
|
Iontophoresis Iontophoresis and Microporation adds up to total Active market. ... |
Upcoming |
|
|
North American Active Transdermal Drug Delivery Devices Market The North American Active Transdermal Drug Delivery Devices Market is mainly driven by patent cliffs and increased incidence of chronic diseases, increasing competition and improving patient compliance, and reformulation and repositioning of drugs, huge investment made by big pharmaceutical companies.The Market was Valued at $712 million in 2013 and expected to be $1339 million by 2018, growing at a CAGR of 13.5 %. The Transdermal Drug Delivery Devices Market analyzes the market by segments such as Active Transdermal Drug Delivery, and Passive Transdermal Drug Delivery. The prominent players in this Market are Novartis, Johnson & Johnson, 3M Company, Noven. |
Upcoming |
|
|
European Active Transdermal Drug Delivery Devices Market The European Active Transdermal Drug Delivery Devices Market is mainly driven by patent cliffs and increased incidence of chronic diseases, increasing competition and improving patient compliance, and reformulation and repositioning of drugs, huge investment made by big pharmaceutical companies.The Market was Valued at $353 million in 2013 and expected to be $633 million by 2018, growing at a CAGR of 12.4 %. The Transdermal Drug Delivery Devices Market analyzes the market by segments such as Active Transdermal Drug Delivery, and Passive Transdermal Drug Delivery. The prominent players in this Market are Novartis, Johnson & Johnson, 3M Company, Noven. |
Upcoming |
|
|
Asian Active Transdermal Drug Delivery Devices Market The Asian Active Transdermal Drug Delivery Devices Market is mainly driven by patent cliffs and increased incidence of chronic diseases, increasing competition and improving patient compliance, and reformulation and repositioning of drugs, huge investment made by big pharmaceutical companies.The Market was Valued at $109 million in 2013 and expected to be $188 million by 2018, growing at a CAGR of 11.6 %. The Transdermal Drug Delivery Devices Market analyzes the market by segments such as Active Transdermal Drug Delivery, and Passive Transdermal Drug Delivery. The prominent players in this Market are Novartis, Johnson & Johnson, 3M Company, Noven. |
Upcoming |
5 reports |
Show
Active
